CLINICAL_TRIALS
trial_result
· 2025-10-21
Clinical Trial Update: Open-Label of SPN-820 in Adults With Major Depressive Disorder [Phase 2]
Summary
A Phase 2 open-label study of SPN-820 in adults with major depressive disorder has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Navitor Pharmaceuticals, Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-10-21